[{"address1": "2533 South Coast Highway 101", "address2": "Suite 210", "city": "Cardiff", "state": "CA", "zip": "92007", "country": "United States", "phone": "858 400 8470", "website": "https://www.viracta.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. The company's Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. Its product pipeline also includes vecabrutinib, a clinical-stage product candidate; and VRx-510, a preclinical product candidate. The company is headquartered in Cardiff, California.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig R. Jalbert CIRA", "age": 62, "title": "CEO, President, CFO, Treasurer, Corporate Secretary & Director", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0179, "open": 0.017, "dayLow": 0.0157, "dayHigh": 0.0196, "regularMarketPreviousClose": 0.0179, "regularMarketOpen": 0.017, "regularMarketDayLow": 0.017, "regularMarketDayHigh": 0.0196, "payoutRatio": 0.0, "beta": 0.252, "forwardPE": -0.032131147, "volume": 198793, "regularMarketVolume": 5094, "averageVolume": 142280, "averageVolume10days": 85170, "averageDailyVolume10Day": 85170, "bid": 0.0152, "ask": 0.0196, "bidSize": 11591, "askSize": 113906, "marketCap": 778986, "fiftyTwoWeekLow": 0.01, "fiftyTwoWeekHigh": 0.82, "fiftyDayAverage": 0.0214, "twoHundredDayAverage": 0.1336, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3494475, "profitMargins": 0.0, "floatShares": 31258036, "sharesOutstanding": 39744200, "sharesShort": 246035, "sharesShortPriorMonth": 2998341, "sharesShortPreviousMonthDate": 1734048000, "dateShortInterest": 1736899200, "sharesPercentSharesOut": 0.0062, "heldPercentInsiders": 0.02987, "heldPercentInstitutions": 0.21264, "shortRatio": 0.11, "shortPercentOfFloat": 0.007900001, "impliedSharesOutstanding": 39744200, "bookValue": -0.166, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -43289000, "trailingEps": -1.1, "forwardEps": -0.61, "lastSplitFactor": "285:1000", "lastSplitDate": 1614211200, "enterpriseToEbitda": 0.075, "52WeekChange": -0.9722222, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 0.01828, "recommendationKey": "none", "totalCash": 21132000, "totalCashPerShare": 0.532, "ebitda": -46773000, "totalDebt": 16911000, "quickRatio": 0.74, "currentRatio": 0.763, "returnOnAssets": -0.66763, "returnOnEquity": -3.70134, "freeCashflow": -23356250, "operatingCashflow": -34796000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "VIRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Viracta Therapeutics, Inc.", "longName": "Viracta Therapeutics, Inc.", "marketState": "CLOSED", "regularMarketDayRange": "0.017 - 0.0196", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 142280, "fiftyTwoWeekLowChange": 0.0096, "fiftyTwoWeekLowChangePercent": 0.96000004, "fiftyTwoWeekRange": "0.01 - 0.82", "fiftyTwoWeekHighChange": -0.8004, "fiftyTwoWeekHighChangePercent": -0.9760976, "fiftyTwoWeekChangePercent": -97.22222, "dividendDate": 1599091200, "earningsTimestampStart": 1748861940, "earningsTimestampEnd": 1749124800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.1, "epsForward": -0.61, "fiftyDayAverageChange": -0.0018000007, "fiftyDayAverageChangePercent": -0.084112175, "twoHundredDayAverageChange": -0.11399999, "twoHundredDayAverageChangePercent": -0.85329336, "priceToBook": -0.11807229, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1127827800000, "regularMarketChange": 0.0017000008, "corporateActions": [], "regularMarketTime": 1748617405, "exchange": "PNK", "messageBoardId": "finmb_38720301", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 9.497211, "regularMarketPrice": 0.0196, "displayName": "Viracta Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]